BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $151,244,000 | +2.2% | 1,000,497 | -1.5% | 0.04% | +8.8% |
| Q2 2022 | $147,955,000 | +8.0% | 1,015,409 | -12.1% | 0.03% | +25.9% |
| Q1 2022 | $136,942,000 | -17.1% | 1,154,954 | -3.7% | 0.03% | -10.0% |
| Q4 2021 | $165,289,000 | -4.8% | 1,199,395 | -4.1% | 0.03% | -11.8% |
| Q3 2021 | $173,701,000 | +45.3% | 1,250,443 | +1.5% | 0.03% | +47.8% |
| Q2 2021 | $119,576,000 | +47.4% | 1,231,728 | +3.8% | 0.02% | +35.3% |
| Q1 2021 | $81,145,000 | +16.7% | 1,187,193 | +46.3% | 0.02% | +13.3% |
| Q4 2020 | $69,561,000 | +34.0% | 811,581 | +1.6% | 0.02% | +15.4% |
| Q3 2020 | $51,909,000 | -10.4% | 798,464 | +0.7% | 0.01% | -13.3% |
| Q2 2020 | $57,944,000 | +142.9% | 792,561 | +13.0% | 0.02% | +87.5% |
| Q1 2020 | $23,858,000 | -20.5% | 701,094 | +27.1% | 0.01% | 0.0% |
| Q4 2019 | $30,024,000 | +28.1% | 551,536 | -1.8% | 0.01% | +33.3% |
| Q3 2019 | $23,436,000 | -1.9% | 561,742 | +3.0% | 0.01% | -14.3% |
| Q2 2019 | $23,892,000 | +186.5% | 545,594 | +236.8% | 0.01% | +250.0% |
| Q1 2019 | $8,339,000 | +64.1% | 162,000 | +17.9% | 0.00% | 0.0% |
| Q4 2018 | $5,083,000 | -3.1% | 137,462 | -1.6% | 0.00% | +100.0% |
| Q3 2018 | $5,246,000 | -6.4% | 139,691 | -1.5% | 0.00% | -50.0% |
| Q2 2018 | $5,603,000 | +79.2% | 141,762 | +16.8% | 0.00% | +100.0% |
| Q1 2018 | $3,127,000 | +170.0% | 121,398 | +182.8% | 0.00% | – |
| Q4 2017 | $1,158,000 | -50.6% | 42,921 | -31.6% | 0.00% | -100.0% |
| Q3 2017 | $2,346,000 | +79.4% | 62,755 | +19.9% | 0.00% | – |
| Q2 2017 | $1,308,000 | – | 52,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |